Skip to main content

MARSHALL WACE, LLP

Position in ALXO — Alx Oncology Holdings Inc

CIK 1318757 LONDON, X0

Position in ALXO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,533,216
+$7,503,412 QoQ
Shares Held
3,757,216
+14144.8% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 68 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALXO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,749,797,393 across 275 Biotechnology names. ALXO ranks #73 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALXO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,533,216 3,757,216
2025-12-31 $29,804 26,376
2025-09-30 $72,436 39,583
2025-06-30 $44,105 106,280
2025-03-31 $168,955 271,197
2024-09-30 $291,307 160,059
2024-06-30 $3,833,144 635,679
2024-03-31 $1,355,237 121,546
2023-12-31 $172,262 11,569
2023-03-31 $79,475 17,583
2022-09-30 $231,373 24,177
2021-12-31 $2,296,743 106,875